Status:
COMPLETED
A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions
Lead Sponsor:
Paddock Laboratories, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) following a si...
Eligibility Criteria
Inclusion
- Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening
Exclusion
- Positive test results for HIV or Hepatitis B or C
- History of allergy or sensitivity to Moexipril HCl or related drugs
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00992862
Last Update
September 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novum Pharmaceutical Research Services
Pittsburgh, Pennsylvania, United States, 15206